IMB-CNM has created a portable and inexpensive device that detects viral RNA in 40 minutes, compared to the hours it takes for methods such as PCR testing. The instrument, tested to detect SARS-CoV-2, could be adapted to diagnose other infectious diseases, which, together with its portability and low cost, opens the door to its use in developing countries

A new method developed by researchers at IMB-CNM allows for high-precision, low-cost fabrication of semiconductor qubits, paving the way for industrial-scale quantum computing

The sensor developed by researchers at IMB-CNM enables the monitoring of sodium, potassium, and pH biomarkers to prevent the adverse effects of dehydration. It incorporates microfluidic elements that provide a constant flow of sweat to the sensor, allowing continuous data collection for over an hour.

The conscious selection of materials and low-impact manufacturing techniques are key to facilitate end-of-life management and ensure the sustainability of the power source. A team from the Institute of Microelectronics of Barcelona (IMB-CNM-CSIC) and BCMaterials lays the foundations of this methodology through the design of a recyclable battery with paper and cardboard for smart packaging.

A team of IMB-CNM-CSIC researchers has coordinated the design of an instrument that combines microfluidics on paper and electrochemical transduction. It easily and quickly detects chronic obstructive pulmonary disease (COPD), the third leading cause of death worldwide, and its versatility allows its application to the detection of other target biomarkers, such as specific RNA sequences of the SARS-CoV-2 virus.

IMB-CNM research staff publishes an exhaustive experimental review of inks, paper substrates and printing techniques, with the aim of offering a guide with data for the scientific community to facilitate the design of printed devices and their ecological manufacture.

The technology company Inbrain, co-founded by CSIC researchers, develops neural implants to decode brain signals and treat diseases such as epilepsy and Parkinson's. New report on the IMB-CNM in the CSIC Investiga magazine.

An international group, in collaboration with the Institute of Microelectronics of Barcelona of the CSIC (IMB-CNM-CSIC), is involved in the development of nanotherapies against cancer using externally controlled nanocapsules. The first results of magnetoplasmonic iron nanocapsules to combat tumors have been obtained in the preclinical phase in mice.